NASDAQ:HSAQ Health Sciences Acquisitions Co. 2 (HSAQ) Stock Price, News & Analysis $5.55 -0.04 (-0.72%) As of 10/26/2026 Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsFinancialsSEC Filings About Health Sciences Acquisitions Co. 2 Stock (NASDAQ:HSAQ) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get HSAQ alerts:Sign Up Key Stats Today's Range$5.52▼$5.6650-Day Range$4.41▼$6.3552-Week Range$9.41▼$13.80Volume242,656 shsAverage Volume205,918 shsMarket Capitalization$62.23 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ) is a special purpose acquisition company (SPAC) formed to identify and complete a business combination with one or more companies in the healthcare and life sciences sectors. The company does not operate as a traditional healthcare provider, pharmaceutical manufacturer, medical-device developer or biotechnology company. Its activities have primarily involved raising capital through a public offering, evaluating potential acquisition targets and pursuing a merger, stock exchange, asset acquisition, reorganization or similar transaction. Because Health Sciences Acquisitions Co. 2 was established as a blank-check company, information about operating products, commercial services, geographic markets and business leadership is limited unless and until it completes a business combination. The company’s future activities would depend on the healthcare or life sciences business it ultimately acquires.AI Generated. May Contain Errors. Read More Receive HSAQ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Health Sciences Acquisitions Co. 2 and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. HSAQ Stock News HeadlinesCardinal Health expands gastroenterology, diabetes businesses with two deals worth $3.9 billionNovember 12, 2024 | msn.comAnalysts Offer Insights on Healthcare Companies: HCA Healthcare (HCA), Exact Sciences (EXAS) and Crispr Therapeutics AG (CRSP)November 6, 2024 | markets.businessinsider.comHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. One day it's a ceasefire, the next it's bombs again. The back and forth may be masking a bigger story most investors are missing. See the real reason this conflict may never fully end.October 27 at 1:00 AM | Banyan Hill Publishing (Ad)Exact Sciences Corporation (EXAS): A Buzzing AI Health Stock to Add to Your PortfolioOctober 5, 2024 | msn.comUS healthtech company Syra closes $2.1m public offeringSeptember 16, 2024 | msn.comQuest Completes Acquisition Of Select Laboratory Assets From Allina HealthSeptember 16, 2024 | markets.businessinsider.comEarnings call: CV Sciences maintains revenue, eyes growth with acquisitionsAugust 15, 2024 | investing.comCommunity Health Systems, Inc. (CYH) Q2 2024 Earnings Call TranscriptJuly 25, 2024 | seekingalpha.comSee More Headlines HSAQ Stock Analysis - Frequently Asked Questions How have HSAQ shares performed this year? Health Sciences Acquisitions Co. 2's stock was trading at $4.15 at the beginning of 2026. Since then, HSAQ stock has increased by 33.7% and is now trading at $5.55. When did Health Sciences Acquisitions Co. 2 IPO? Health Sciences Acquisitions Co. 2 (HSAQ) raised $139 million in an initial public offering on Tuesday, August 4th 2020. The company issued 13,900,000 shares at $10.00 per share. Chardan and Barclays acted as the underwriters for the IPO. How do I buy shares of Health Sciences Acquisitions Co. 2? Shares of HSAQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today10/27/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:HSAQ CIK1814114 WebN/A PhoneN/AFaxN/AEmployees4Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$380 thousand Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-2.38% Debt Debt-to-Equity RatioN/A Current Ratio0.17 Quick Ratio0.61 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($0.62) per share Price / Book-8.95Miscellaneous Outstanding Shares11,212,000Free Float8,757,000Market Cap$62.23 million OptionableNot Optionable Beta0.09 The Infrastructure's Backbone: 10 Stocks Powering the AI BuildoutThe AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.Get This Free Report This page (NASDAQ:HSAQ) was last updated on 10/26/2026 by MarketBeat.com Staff. From Our PartnersFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredMy next big call (under $1)17,556% on KDA. 3,900% on PRE. 2,650% on OCEAN. Every single one of these was recommended to our community bef...Crypto 101 Media | SponsoredHe turned $12K into $1.65M without touching Apple or TeslaTim Sykes turned $12,415 in gift money into more than $1.65 million before graduating college, without trading...Tim Sykes | SponsoredLast call for your free 0DTE reportThe 0DTE Game Plan lays out a simple 3-step framework for trading same-day options: Plan it, profit from it, p...Profits Run | SponsoredWhy Gerardo Del Real says wait before buying uranium stocksGerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he ...Digest Publishing | SponsoredFirst Look: Elon’s “Starphone”Rumors are swirling that Elon Musk is developing a new mobile device that could rival the iPhone. It's said to...Stansberry Research | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Health Sciences Acquisitions Co. 2 Please log in to your account or sign up in order to add this asset to your watchlist. Share Health Sciences Acquisitions Co. 2 With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
